Skip to content

Released Nov 12, 2013, after the close

10-Q filed Nov 13, 2013, 44 days after period end · 0001193125-13-438833

Q3 2013 · 10-Q
Revenue$0.00— vs Q3 2012no prior Q2 2013 on file
Net Income-$3.48MN/M vs Q3 2012N/M vs Q2 2013
EPS Diluted-$0.39N/M vs Q3 2012N/M vs Q2 2013
Operating Income-$3,545,765N/M
Operating Cash Flowderived-$4,474,821—
Free Cash Flowderived-$4,474,821—

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

MetricQ3 2013Q3 2012Q3 2011
Revenue$0.00$0.00$0.00
Net Income-$3.48M-$1.01M$0.00
EPS Diluted-$0.39-$0.23$0.00

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Lipocine Inc. · CIK 1535955 · Engraved from SEC EDGAR